Skip to Content
 

News: Lung Cancer

High fiber, yogurt diet associated with lower lung cancer risk

Monday, October 28th, 2019

A diet high in fiber and yogurt is associated with a reduced risk for lung cancer, according to a study by Vanderbilt University Medical Center researchers.

Clinical study tests drug that may prevent cancer metastasis

Thursday, July 11th, 2019

A clinical study of a drug that may block cancer metastasis is currently enrolling patients at the Vanderbilt-Ingram Cancer Center.

Health disparity for blacks exists within lung screening guidelines

Saturday, June 29th, 2019

The U.S. Preventive Services Task Force (USPSTF) guidelines that determine which smokers qualify for CT scans exclude significant numbers of African Americans who develop lung cancer, a health disparity that merits modifications to lung cancer screening criteria, according to a study from Vanderbilt researchers.

Immunotherapy helping 87-year-old man stay on the job

Friday, June 7th, 2019

Immunotherapy is helping cancer patient Roszell Mack Jr. to continue going to his job on a Kentucky horse farm.

Team explores fungal infection quandary in lung cancer screenings

Thursday, April 25th, 2019

A recent study by Vanderbilt investigators revealed that histoplasmosis – a fungal infection that creates cancer-mimicking lesions in the lungs – is prevalent beyond previously identified regions of the United States.

Asian nations in early tobacco epidemic: study

Thursday, April 25th, 2019

Asian countries are in the early stages of a tobacco smoking epidemic with habits mirroring those of the United States from past decades, setting the stage for a spike in future deaths from smoking-related diseases.

Study reframes approach to targeted therapy resistance

Thursday, April 25th, 2019

A recent study provides clinicians genomic guidance for surveillance of targeted therapy resistance in patients with EGFR-mutant non-small cell lung cancer — and more importantly — another drug option when resistance occurs.

New algorithm calculates drug synergy; initial tests involve melanoma, lung cancer

Monday, February 25th, 2019

Drug combinations used for the treatment of non-small-cell lung cancer (NSCLC) and melanoma aren’t as effective as they could be. That could change with a new algorithm developed by a cross-disciplinary Vanderbilt University team for calculating drug synergy.

Spalluto, Lewis to lead VA lung screening initiative

Friday, January 18th, 2019

Lucy Spalluto, MD, and Jennifer Lewis, MD, MS, are co-leading the Veterans Affairs-Partnership to increase Access to Lung Screening (VA-PALS) National Program Evaluation, which aims to implement lung screening programs and improve access to early detection of lung cancer for at-risk veterans.

Lung cancer survival signal

Saturday, December 1st, 2018

A recent study shows that a cell receptor, SSTR2, is a candidate biomarker for poor prognosis and a potential therapeutic target for small cell lung cancer.

Next Page »